Podcasts about khiron

Vicente Fox mintió. Sí está vinculado con los permisos irregulares de Cofepris para comercialización de productos con marihuana, emitidos nueve días antes de que terminara el gobierno de Peña Nieto

Today, we have another incredible guest, Benjamin Fry. An Eton and Oxford graduate, Benjamin started out his career after film school with work that was distributed by giants HBO and Paramount, he was also a nightlife entrepreneur, and a BBC television presenter. This list of eclectic experiences eventually led him to train as a psychotherapist and author his first book of three.But with all this success, Benji's story took a significant turn when he personally grappled with a breakdown as he neared 40, an experience that gave him a unique perspective on the state of mental health support, particularly for men. Using his business acumen, media skills, and clinical training, he founded Khiron Clinics, one of the only residential trauma-treatment centres globally.Whilst stepping back from the day to day of Khiron, Benjamin now offers therapy to couples, helping them heal their relationships with the knowledge and tools gained from his own experiences and professional training.If you want to hear a raw and unfiltered story of a man who society would see as having everything but felt like he had nothing and his path back, then this is the episode for you.

Khiron is taking a different approach than US Cannabis companies. They are building data systems to provide evidence-based research to reduce stigma, adopt normalization, and convert opioid users to medical cannabis. Their systems and achievement have quickly led to many breakthroughs, as recently announced, "Khiron signs deal with Bogota's largest public health insurance for medical cannabis coverage." Now that Columbia is on board, Khiron has its eyes on disrupting other international medical markets by taking the data-based evidence to Brazil, Peru, Mexico, and many othersThis week on The Dime, we host Alvaro Torres, CEO of Khiron, to discussProviding data-based evidence to influence regulatorsInternational challenges & opportunitiesBuilding foundational systems for personalized medicineHow US Cannabis companies are looking to replicate Khiron's international successand so much moreAbout Khiron A GLOBAL MEDICAL CANNABIS COMPANY IMPROVING THE QUALITY OF PEOPLES' LIVES.We believe in the benefits of medical cannabis to improve people's quality of life through the development of high-quality pharmaceutical products, continuous medical education for health professionals, and permanent monitoring of the patient in their treatment, through the Patient Follow-up Program.#CannabisInsier #KHRN #GlobalCannabis TSXV: KHRN | OTCQX: KHRNF #cannnabisinsider #internationalcannabis #KHRNFKhiron Links:https://khiron.ca/https://twitter.com/khironlifehttps://www.instagram.com/khironlife/?hl=enhttps://www.linkedin.com/in/alvaroftorres/?originalSubdomain=cohttps://twitter.com/alvarotorresrue Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

Khiron is taking a different approach than US Cannabis companies. They are building data systems to provide evidence-based research to reduce stigma, adopt normalization, and convert opioid users to medical cannabis. Their systems and achievement have quickly led to many breakthroughs, as recently announced, "Khiron signs deal with Bogota's largest public health insurance for medical cannabis coverage." Now that Columbia is on board, Khiron has its eyes on disrupting other international medical markets by taking the data-based evidence to Brazil, Peru, Mexico, and many othersThis week on The Dime, we host Alvaro Torres, CEO of Khiron, to discussProviding data-based evidence to influence regulatorsInternational challenges & opportunitiesBuilding foundational systems for personalized medicineHow US Cannabis companies are looking to replicate Khiron's international successand so much moreAbout Khiron A GLOBAL MEDICAL CANNABIS COMPANY IMPROVING THE QUALITY OF PEOPLES' LIVES.We believe in the benefits of medical cannabis to improve people's quality of life through the development of high-quality pharmaceutical products, continuous medical education for health professionals, and permanent monitoring of the patient in their treatment, through the Patient Follow-up Program.#CannabisInsier #KHRN #GlobalCannabis TSXV: KHRN | OTCQX: KHRNF #cannnabisinsider #internationalcannabis #KHRNFKhiron Links:https://khiron.ca/https://twitter.com/khironlifehttps://www.instagram.com/khironlife/?hl=enhttps://www.linkedin.com/in/alvaroftorres/?originalSubdomain=cohttps://twitter.com/alvarotorresrue Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

Khiron is taking a different approach than US Cannabis companies. They are building data systems to provide evidence-based research to reduce stigma, adopt normalization, and convert opioid users to medical cannabis. Their systems and achievement have quickly led to many breakthroughs, as recently announced, "Khiron signs deal with Bogota's largest public health insurance for medical cannabis coverage." Now that Columbia is on board, Khiron has its eyes on disrupting other international medical markets by taking the data-based evidence to Brazil, Peru, Mexico, and many othersThis week on The Dime, we host Alvaro Torres, CEO of Khiron, to discussProviding data-based evidence to influence regulatorsInternational challenges & opportunitiesBuilding foundational systems for personalized medicineHow US Cannabis companies are looking to replicate Khiron's international successand so much moreAbout Khiron A GLOBAL MEDICAL CANNABIS COMPANY IMPROVING THE QUALITY OF PEOPLES' LIVES.We believe in the benefits of medical cannabis to improve people's quality of life through the development of high-quality pharmaceutical products, continuous medical education for health professionals, and permanent monitoring of the patient in their treatment, through the Patient Follow-up Program.#CannabisInsier #KHRN #GlobalCannabis TSXV: KHRN | OTCQX: KHRNF #cannnabisinsider #internationalcannabis #KHRNFKhiron Links:https://khiron.ca/https://twitter.com/khironlifehttps://www.instagram.com/khironlife/?hl=enhttps://www.linkedin.com/in/alvaroftorres/?originalSubdomain=cohttps://twitter.com/alvarotorresrue Follow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

In the material plane, Esther and Winswip air their grievances and Aveline faces a test of her faith. In the ethereal plane, Khiron makes a confession. And from somewhere in between, Quaris speaks.  JOIN OUR DISCORD! www.questlaidplans.com/discord http://bit.ly/questlaiddiscord FOLLOW US ON TWITTER! @QuestLaidPlans Subscribe to our Patreon! https://www.patreon.com/questlaidplans Game Master: Meghan Kelleher @meghankelleher3 Cast: Jamie Rose Hathaway @jamiedotrose Jesse B. Koehler @jb_koehler Maya S. Ming @mayascape Neda Marie Valcheva @NedaMarie Phil Arevalo @PhilAArevalo Creative Consultant: Nicky Nenkov @nickynenkov Character Artist: Pamella Kokalova @pamellkaaa Music tracks featured in this episode: “Reunion (Previously On Ver.)” by Meghan Kelleher “Reunion (Quest Laid Plans Theme Song)” by Meghan Kelleher “The Last Ten Years” by Meghan Kelleher "Cruel as the Grave" by Meghan Kelleher "You Can't Kill Me" by Meghan Kelleher

How important are THC:CBD ratios?On the latest episode of The Cannabis Conversation, we're joined by Guillermo Moreno-Sanz, PhD of Khiron Life Sciences Corp - a global provider of cannabis-based medicines and healthcare services.We explore how THC and CBD work on the body individually, our current understanding on how they interact together, and discuss the recent findings of the King's College study on THC and CBD interaction.The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at www.luminorecruit.com/About Guillermo Moreno-Sanz, PhDGuillermo Moreno-Sanz, PhD has been dedicated to cannabinoid research for almost 20 years and has authored more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. He received his degree in Biochemistry and Organic Chemistry from the University of Zaragoza, and his PhD in Neurosciences from the Complutense University of Madrid, Spain. He gained extensive international experience with long-term fellowships at the University of Leiden in the Netherlands and at the Department of Drug Discovery and Development at the Italian Institute of Technology in Genoa, Italy. Dr. Moreno-Sanz was awarded a Fulbright Scholarship to complete his Ph.D. in the United States, spending most of his academic career at the University of California, Irvine. There he discovered and characterized a new class of cannabinoid analgesics that are currently in clinical development. In 2017, Dr. Moreno-Sanz served as a consultant to the U.S. National Academies of Sciences in the development of the report "The Health Effects of Cannabis and Cannabinoids" and founded his own consulting firm, Abagune Research, to provide scientific advice and R&D solutions to leading companies in the cannabis industry internationally. In 2020, he joined Khiron Life Sciences Corp as scientific and medical director for Europe and, in 2021 he became the scientific director of the company. Khiron Life Sciences is a global provider of cannabis-based medicines and healthcare services through its network of Zerenia™ clinics, with a presence in Colombia, Peru, Brazil, UK, and Germany.ResourcesConnect with Guillermo Moreno-Sanz, PhD on LinkedIn: https://www.linkedin.com/in/guillermomorenosanzKhiron Med's Website: https://khironmed.co.uk/

Conversamos con Álvaro Torres, CEO de Khiron Life Sciences, sobre la historia de la compañía, sus alcances y planes para el corto y mediano plazo, así como los retos que enfrenta el sector del cannabis medicinal en el mundo. Álvaro Torres es es CEO y director de Khiron, empresa que co-fundó en 2017 y actualmente es líder en el sector del cannabis medicinal en Colombia y el Reino Unido, con una estrategia de crecimiento para Perú, Brasil, México y el mercado europeo. El ejecutivo nos cuenta sobre cómo ha funcionado la estrategia de no abordar la planta cannabis como un commodity sino enfocarse en la generación de mercado a través de educación a médicos y la apertura de la cadena de clínicas de cannabis medicinal Zerenia.

Conversamos con el Dr. Guillermo Moreno-Sanz, director científico de Khiron Life Sciences sobre su trayectoria profesional y los desafíos que enfrenta la investigación en el sector del cannabis medicinal. El Dr. Moreno-Sanz tiene dos décadas de experiencia en la investigación de los cannabinoides y es autor de artículos científicos y pantentes en torno al sistema endocannabinoide. Es licenciado en Bioquímica y Química Orgánica por la Universidad de Zaragoza y doctor en Neurociencia por la Universidad Complutense de Madrid. Obtuvo una beca Fulbright para completar su doctorado en Estados Unidos, desarrollando la mayor parte de su carrera académica en la Universidad de California, campus Irvine.

PharmaDrug Inc chairman and CEO Daniel Cohen joined Proactive's Stephen Gunnion with details of the sale of its German medical cannabis distributing subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp. Cohen telling Proactive that the company has managed to "have its cake and eat it" as it will get 5,500,000 common shares of Khiron and a non-interest bearing promissory note in the principal amount of $1.1 million, payable one year from the date of issue. While the transaction will be a major step towards PharmaDrug's shift into a pure-play biotech company, he said it will retain exposure to the growing German and UK cannabis market through the Khiron stake.

There's no romantic  origin story of how Alvaro Torres, CEO and Co-founder of Khiron Life Sciences,  a Colombian medical cannabis company, got into the sector.And for this reason, it would be tempting to assume the company was started to make the most of the worldwide cannabis green rush with little concern for patients. It would seem though that at Khiron, Torres and his team strive towards making patients the centre of the business model, whether it's their established clinics in Colombia or their more recent concerns in the UK and Germany. This is a great interview for cannabis industry professionals and patients alike, as it shows how humanity does not have to be lost when creating a successful medical cannabis company. In fact, it might just work in its favour.Useful links:https://khiron.ca/https://khironmed.co.uk/https://zereniaclinic.co.uk/Support the show

In this episode of Cannabis Unlocked, Alvaro Torres (Co-Founder, CEO & Director of Khiron Life Sciences Corp.) and Jordan Youkilis (KEY Founding Partner) discuss the growth of Colombian cannabis and it's competitive advantages on other international medical cannabis producers. Today's conversation starts with Alvaro's company, Khiron's, creation story and journey to its current international market dominance. From there, Alvaro and Jordan speak to the current financial edge cannabis operators in Colombia have when it comes to competing internationally. The conversation wraps up with the importance of educating medical practitioners about the medicinal values of cannabis and how doctors are the key to patient access and growth of the medical cannabis industry. Please enjoy!

Reefer Reporters - April 7 2022 with Glenn & AlStories include....Labatt shutters CBD beverage unit in Canada in latest blow to category, Winnipeg pushes medical cannabis grow-ops out of residential neighbourhoods, Ontario study shows illicit edibles have significantly less THC than advertised, high levels of pesticides, BC government asking for input on cannabis consumption lounges, Maple Ridge council stops government cannabis store, Regulate cannabis like corn? US Farm Bill proposal raises eyebrows, hopes, More than half of Europeans support cannabis legalization -report, 92% of patients report improvements in chronic pain after using cannabis oil: Khiron study, Does Cheap Weed Give You A Good High?, Russian invasion of Ukraine further upends cannabis supply chain

Global cannabis opportunities.      Alvaro Torres is CEO of  Khiron Life Science (KHRN: CA) a company with operations in Columbia, Peru, Germany, and the UK is back for Part 2 of his interview with Dan Humiston.   He discusses their plans to capitalize on the upcoming opportunities in Mexico.  He also shares an overview of their 2021 year-end results and 2023 projections. Produced by PodConx MJBulls - https://podconx.com/podcasts/raising-cannabis-capitalDan Humiston - https://podconx.com/guests/dan-humistonKhiron Investors - https://investors.khiron.ca/corporate-informationKhiron - https://khiron.ca/Alvaro Torres - https://podconx.com/guests/alvaro-torres

Exciting Latin America and European growth.   With the enormous growth of cannabis in North America it is easy to overlook its global expansion.   Alvaro Torres is CEO of  Khiron Life Science (KHRN: CA) a company with operations in Columbia, Peru, Germany and the UK.  He joins Dan Humiston to talk about their exciting growth and some key break-throughs including Columbia covering cannabis in their health insurance.Produced by PodConX MJBulls - https://podconx.com/podcasts/raising-cannabis-capitalDan Humiston - https://podconx.com/guests/dan-humistonKhiron Investors - https://investors.khiron.ca/corporate-informationKhiron - https://khiron.ca/Alvaro Torres - https://podconx.com/guests/alvaro-torres

Last month, the recently elected coalition government in Germany announced their initial plans to legalise cannabis for recreational use.There has understandably been a lot of excitement about this news, so on this week's episode Alfredo Pascual from Seed Innovations, Franziska Katterbach from Khiron Life Sciences, and Tom Blickman from Transnational Institute join me to discuss how the upcoming legislation may disrupt and revolutionise the recreational and medical markets within Germany and Europe on a wider scale.About Our GuestsAlfredo PascualVP of Investment Analysis, Seed Innovations Based in Germany, Alfredo is a prominent cannabis industry analyst who has been identifying opportunities and generating unique insights for businesses and investors in Europe and Latin America since 2016. He is currently VP of Investment Analysis of Seed Innovations Ltd (LON: SEED), the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space. Before joining Seed Innovations, Alfredo worked as International Analyst at Marijuana Business Daily (MJBiz), the US-based business news and information resource, where he focused on covering how cannabis markets and investments were evolving internationally. Alfredo has an academic background in business and public policy.Connect with Alfredo on LinkedIn: https://www.linkedin.com/in/alfrepTom BlickmanSenior Project Officer, Transnational InstituteTom Blickman (1957) is a Senior Project Officer at the Transnational Institute (TNI), based in Amsterdam. Since 1997, he has been working for TNI's Drugs Programme, specializing in international drug control policy and the UN conventions, drug markets, alternative development, money laundering and organised crime. More recently he is closely following cannabis regulation policies in Europe and elsewhere. Tom is a regular speaker at international policy conferences and advises on developments in the drugs field. He is co-editor of the TNI Drug Policy Briefing series.Connect with Tom on LinkedIn: https://www.linkedin.com/in/tom-blickman-2941a046/Franziska KatterbachPresident, Khiron Life SciencesFranziska Katterbach is an accomplished business executive and legal expert (zugelassene Rechtsanwältin) who brings extensive experience working within Europe's emerging cannabis industry. After completing her legal studies at Universität Leipzig and Landgericht Darmstadt, Franziska joined the corporate law firm Dentons, where she was involved in high-profile deals in the cannabis sector across multiple jurisdictions. Franziska later served as Director of Legal for Canopy's European operations, before joining Khiron. With 8+ years of regulatory expertise and 4+ as business executive in the European emerging cannabis industry, Franziska has well rounded knowledge in the industry. Franziska is considered a pioneer of the medical cannabis market in Germany, working in the medical cannabis industry in Europe on executive level since the very beginning in 2016.Connect with Franziska on LinkedIn: https://www.linkedin.com/in/franziska-katterbach-438878a9

Reefer Reporters for Thursday November 4, 2021– with Cindy and Ron. Stories include…Amendment to Cannabis Legislation Protects Nova Scotians from Unreasonable Searches; ‘Wunderkind' CEO of Neptune cannabis firm granted CA$69 million in compensation over 2 years; Only 484 marijuana pardons have been granted since program started in 2019; Organigram doubled Canadian cannabis market share since January; Support For Marijuana Legalization In Pennsylvania Hits Record High, New Poll Finds; State official: Enrollment in Medical Cannabis Program grew 72 percent in 2 years; Montana Marijuana Regulators Push Strict Ban On Industry Workers With Any Kind Of Criminal Convictions; California legalized weed five years ago. Why is the illicit market still thriving?; Khiron opens its first medical cannabis clinic in Europe; ‘It's mind-boggling': the complex, and growing, use of medicinal cannabis in AustraliaTY Bma Hydroponics Dr. Buck CTS Campbellford Lifestyle Shop Legacy420.com

In Episode #79, we are joined by Marco Algorta, Public Relations Manager at Khiron Life Sciences and a cannabis activist in Uruguay. We discuss: Why Marco is less bullish about Uruguay's cannabis sector than he was a few years ago. Uruguay's strengths and weaknesses as a cannabis actor. What Uruguay needs to do to get its canna mojo back. Uruguay's broader political and economic environment. Colombia and other countries to watch in Latam when it comes to cannabis. Marco's experience setting up CannaPur and selling it to Khiron. What makes canna startups thrive (or fail). Regional differences in Marco's native Brazil. Uruguay's outsized role in world football/soccer. Listening, and watching recommendations from: Marco Don Quijote de la Mancha, by Miguel de Cervantes  Jonathan Five Kingdoms, by Brandon Mull Fred Red Roulette: An Insider's Story of Wealth, Power, Corruption, and Vengeance in Today's China, by Desmond Shum We'll see you next week for another exciting and informative episode when we sit down with Gregory Schaffer, author of Emerging Powers and the World Trading System.

We chat with Ted Ohashi, writer of "The Cannabis Report" on Investors Hub, about what is going on in the world of cannabis. Amazon announced last week that they were more strongly supporting pro-cannabis legislation. The House of Representatives also attached the SAFE act to a "must pass" bill to try and sneak it through 0:00 Intro with Disclaimer 0:45 Amazon to the Rescue? 4:10 What Happens After SAFE Banking Act 6:14 Model Portfolio Update 9:24 Final Thoughts and Disclosures Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca !Disclosures: Ted says he has no shares in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

We chat with Ted Ohashi, writer of "The Cannabis Report," about the latest and greatest with Khiron and Jushi. We also chat about how local governments below the state level and upcoming inflation could impact industry growth. 0:00 Intro with Disclaimer 0:56 Local Governments' Impacts on Cannabis 3:15 Interest Rates on Cannabis Companies 7:26 Khiron KHRNF 9:58 Jushi JUSHF 11:28 Final Thoughts and Disclosures Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca !Disclosures: Ted says he has no shares in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. Website: https://investorshub.advfn.com/ Market Vision Twitter: https://twitter.com/IHub_Vision Investors Hub Twitter: https://twitter.com/Investors_Hub Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/ Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc- Investors Hub Facebook: https://www.facebook.com/InvestorsHub #stocks #cannabis #investing --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Ted is back for another week! He shares what is going on with some companies in his model portfolio, including Lexaria, Khiron, and Kiaro! 0:00 Intro with Disclaimer 0:42 THC vs CBD vs Industrial Hemp 1:48 Hemp Concrete? 2:19 Model Portfolio Update 6:07 Interview with Kiaro 7:00 Final Thoughts Ted's interview with Kiaro: http://www.investmentpitch.com/video/1_nb9xhn3m/Kiaro-Holdings-CEO-Daniel-Petrov-is-interviewed-by-Ted-Ohashi-of-Lets-Toke-Business Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca !Disclosures: Ted says he has no shares in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. Website: https://investorshub.advfn.com/ Market Vision Twitter: https://twitter.com/IHub_Vision Investors Hub Twitter: https://twitter.com/Investors_Hub Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/ Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc- Investors Hub Facebook: https://www.facebook.com/InvestorsHub #stocks #cannabis #investing --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

El vicepresidente de Khiron destacó en BLU Radio el paso que dio el Gobierno para entrar en esta industria. See omnystudio.com/listener for privacy information.

Check out the latest Ted Tuesday! We chat with Ted Ohashi about the new cannabis law from Chuck Schumer, the Cannabis Administration and Opportunity Act (CAOA). We also discuss how inflation impacts cannabis and a brand new company in his model portfolio, Kiaro Holdings TSXV:KO! Check out the video on YouTube!: https://youtu.be/PdC4rzXwctQ 0:00 Intro with Disclaimer 1:14 Schumer's New Cannabis Bill 3:19 CPI and Inflation on Cannabis 5:09 Cannabis Companies Have Enough Workers? 6:43 Kiaro (TSXV KO) 9:05 Khiron 10:45 Final Thoughts and Disclosures Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca !Disclosures: Ted says he has no shares in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. Khiron (KHRNF): https://ih.advfn.com/stock-market/USOTC/khiron-life-sciences-qx-KHRNF/stock-price Kiaro Holdings: https://ih.advfn.com/stock-market/TSXV/KO/stock-price Website: https://investorshub.advfn.com/ Market Vision Twitter: https://twitter.com/IHub_Vision Investors Hub Twitter: https://twitter.com/Investors_Hub Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/ Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc- Investors Hub Facebook: https://www.facebook.com/InvestorsHub #stocks #cannabis #investing --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Check out the latest Ted Tuesday! We chat with Ted Ohashi about what is going on in the cannabis industry and some developments from companies in his model portfolio! Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca !Disclosures: Ted says he has no positions in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. Website: https://investorshub.advfn.com/ Market Vision Twitter: https://twitter.com/IHub_Vision Investors Hub Twitter: https://twitter.com/Investors_Hub Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/ Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc- Investors Hub Facebook: https://www.facebook.com/InvestorsHub #stocks #cannabis #investing --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Alvaro Torres is an entrepreneur and executive with over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. He's overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia's tallest skyscraper. Khiron Life Sciences Corp's intent is to position itself to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, Khiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people Summary: 00:00 - Intro 03:47 - Cannabis Health Centers 11:08 - Growing Cannabis in Colombia 17:43 - Flower's stigma, extracts only 22:18 - Converting Drs to cannabis 28:32 - Cannabis covered by Insurance 36:34 - $.05/g & 90% gross profit 43:36 - Advice for Lat. Am. 48:09 - Alavro's last words 50:31 - outro Show Notes: Alvaro Torres, Co-Founder, CEO and Director at Khiron Life Sciences Corp https://www.linkedin.com/in/alvaroftorres/?originalSubdomain=co Khiron Life Sciences Corp https://khiron.ca Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 747 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Beat | Keep On | 2020 Artist: Milochromatic Beats & Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018 Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

Alvaro Torres is an entrepreneur and executive with over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. He's overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia's tallest skyscraper. Khiron Life Sciences Corp's intent is to position itself to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, Khiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people Summary: 00:00 - Intro 03:47 - Cannabis Health Centers 11:08 - Growing Cannabis in Colombia 17:43 - Flower's stigma, extracts only 22:18 - Converting Drs to cannabis 28:32 - Cannabis covered by Insurance 36:34 - $.05/g & 90% gross profit 43:36 - Advice for Lat. Am. 48:09 - Alavro's last words 50:31 - outro Show Notes: Alvaro Torres, Co-Founder, CEO and Director at Khiron Life Sciences Corp https://www.linkedin.com/in/alvaroftorres/?originalSubdomain=co Khiron Life Sciences Corp https://khiron.ca Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 747 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Beat | Keep On | 2020 Artist: Milochromatic Beats & Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018 Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers. --- Support this podcast: https://anchor.fm/talkinghedge/support

Alvaro Torres is an entrepreneur and executive with over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. He's overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia's tallest skyscraper. Khiron Life Sciences Corp's intent is to position itself to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, Khiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people Summary: 00:00 - Intro 03:47 - Cannabis Health Centers 11:08 - Growing Cannabis in Colombia 17:43 - Flower's stigma, extracts only 22:18 - Converting Drs to cannabis 28:32 - Cannabis covered by Insurance 36:34 - $.05/g & 90% gross profit 43:36 - Advice for Lat. Am. 48:09 - Alavro's last words 50:31 - outro Show Notes: Alvaro Torres, Co-Founder, CEO and Director at Khiron Life Sciences Corp https://www.linkedin.com/in/alvaroftorres/?originalSubdomain=co Khiron Life Sciences Corp https://khiron.ca Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 747 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Beat | Keep On | 2020 Artist: Milochromatic Beats & Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018 Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

We are kicking off June with a Ted Tuesday! We chat with Ted Ohashi, writer of "The Cannabis Report", about how cannabis companies will develop. He also shares some new things from companies in his model portfolio including Khiron and Lexaria. Ted on Facebook: https://www.facebook.com/letstokebiz/ Ted on LinkedIn: https://www.linkedin.com/in/tedohashi/?originalSubdomain=ca 0:00 Intro with Disclaimer 0:54 Cannabis Company Comparison 2:20 Room for the Little Guy? 3:58 First-Mover Advantage? 6:51 Model Portfolio Developments 8:18 Companies Outside Portfolio 10:10 Final Thoughts and Disclosures !Disclosures: Ted says he has no positions in the companies mentioned !!We produce videos and content to share the perspective of different investors. No video we produce is designed to be direct investing advice, and the investing opinions of our guests are their own. Invest at your own risk. Do your due diligence. Khiron (KHRNF): https://ih.advfn.com/stock-market/USOTC/khiron-life-sciences-qx-KHRNF/stock-price Lexaria (LEXX): https://ih.advfn.com/stock-market/NASDAQ/lexaria-bioscience-LEXX/stock-price Website: https://investorshub.advfn.com/ Market Vision Twitter: https://twitter.com/IHub_Vision Investors Hub Twitter: https://twitter.com/Investors_Hub Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/ Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc- Investors Hub Facebook: https://www.facebook.com/InvestorsHub #stocks #cannabis #investing --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Ritorna il format #impresacannabis, con le interviste agli attori delle tante imprese che lavorano nel settore cannabis. Oggi la dr.ssa Viola Brugnatelli e il dr. Guillermo Moreno-Sanz, scienziato specializzato nella cannabis ed endocannabinologia, fondatore di Abagune Research e direttore medico scientifico per l’Europa della azienda di cannabis Khiron, fanno quattro chiacchiere sulla figura del consulente scientifico nel settore cannabis.

In a troubling and unpredictable year, blockchain and cannabis have been some of the best investments and two industries most primed for growth. Chris Naprawa, Director and Chairman of the Board at Khiron and President at TAAL Distributed Information Technologies, shares his insights on both paradigm-shifting industries. Why BSV is the protocol of the future, and why TAAL is in position to capitalize on that. Importance of data. Solving for the consumer and regulatory compliance. Future of cannabis in South America, Brazil set to be biggest medical market, Colombia demographics an advantage and accessing capital at a cost you can live with. Learn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis News Update December 14, 2020 Today in the world of cannabis: Nextleaf receives its 11th U.S. patent, Khiron becomes the first company to export medical cannabis from Colombia to Peru, and Canopy Growth focuses on profits at the expense of hundreds of employees. The Morning Buzz presented by TRICHOMES brings you late-breaking news that tells you what's happening within the cannabis industry. Check in with the cannabis community at TRICHOMES.com

Celebrating our 100th episode! Alvaro Torres, co-founder and CEO of Khiron, joins us to discuss building value in LatAm and Europe and why a strong foundation is essential. Following its recent Q3 earnings and some bullish announcements, we also cover why Khiron wanted to avoid treating cannabis as a commodity. Sustainable patient growth with good margins. Staying the course. Slow, but present, European growth; CBD skincare in Hong Kong; growth in Mexico, Colombia and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we're joined by Tejinder Virk, European President of Khiron Life Sciences, a vertically integrated medical cannabis company with operations across Latin America, Europe and North America. Join us as we look into Khiron's operations within Colombia, alongside the increasingly progressive cannabis landscape in South America. → View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode84About TejinderTejinder is a proven leader with over 15 years of executive-level experience in the capital markets and cannabis industries. Tejinder previously served as Managing Director, Europe, for Canopy Growth Corporation, where he was responsible for driving the multinational expansion of Canopy's European operations. He was also formerly Managing Director of Global Equity Products for BMO Capital Markets, a role which saw him developing and managing major client relationships across EMEA.QuotablesEurope is a ‘frontier' market for cannabis 02:45ResourcesJoin Tejinder on LinkedIn: https://www.linkedin.com/in/tejinder-virk-52403769/?originalSubdomain=ukFollow Khiron Life Sciences Corp. on LinkedIn: https://www.linkedin.com/company/khiron-life-sciences-corp/Khiron Life Sciences Corp.'sWebsite: https://www.khiron.ca/

On this week's Colombia Calling podcast we have the opportunity to converse with Alvaro Torres, CEO and co founder of Khiron Life Sciences, one of the pioneers in the medical marijuana market from Colombia. Torres tells us about his background, how he got into this business and what the business is all about. Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading cannabis company in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Peru and has a presence in Mexico, Uruguay, UK, Spain and also in Germany, where it is positioned to begin sales of medical cannabis. Tune in for a fascinating episode and check out http://khiron.ca/

Alvaro Torres is the Co-Founder and CEO of Khiron Life Sciences Corporation, which is the first fully licensed medical cannabis company in Colombia. Khiron's core operations include the cultivation, production, domestic distribution, and international export of both THC and CBD cannabinoids.

En la emisión 25 de Cannabis Hispano:.- Khiron firma acuerdo de distribución de cannabis medicinal en Colombia con Locatel.- El uso industrial de la marihuana ayudará a reactivar la economía de México.- ¿Quiénes pueden comprar marihuana en Uruguay?

Khiron recibe primeras recetas médicas de cannabis para pacientes del Reino Unido que participan en Proyecto #Twenty21 // Solicitantes de empleo de cannabis en Canadá aumentan // Canopy Rivers invierte $2 millones en una empresa de gominolas en Canadá // Mercado europeo del cannabis vale 240 millones de euros

Tune in to this week's pod to hear insights from the President of Europe for Khiron Life Sciences, a Canadian-based cannabis LP with major facilities and operations in Colombia.   Tej takes us through how their recently acquired certifications and licenses will help to provide cannabis medicines to thousands in Colombia, Khiron’s European footprint within the medical cannabis market, and how telemedicine is going to increase patient access during this global pandemic and beyond.

La empresa Khiron recibió en una semana más de 1.000 currículum de personas y empresas interesadas en trabajar en la planta de producción de cannabis medicinal que se instalará en un predio cercado a la ciudad de Juan Lacaze, en Colonia. Según informó en Puntos de vista la corresponsal de RNU Stephanie Menéndez, los trabajadores de exFanapel ayudan a armar y o enviar los currículum a todos los interesados que no cuentan con las herramientas necesarias para hacerlo, ya que la postulación es solamente a través de un mail. --- Send in a voice message: https://anchor.fm/mediospublicosu/message

Chris Naprawa is President at Khiron Life Sciences. Chris joins Rena Sherbill to discuss Khiron's focus on Latin America and beyond and its plans for growth, including partnerships and acquisitions. They also discuss global deregulation, Khiron's recent equity offerings and the benefits of having a former President on its board. Learn more about your ad choices. Visit megaphone.fm/adchoices

Joining the GritCast Podcast is Chris Naprawa, President of Khiron Life Sciences! Giving us an update on the Latin America cannabis market and how Khiron is set to be the dominate player!

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aphria (TSX: APHA) (NYSE: APHA), Choom (CSE: CHOO), Aurora (TSX: ACB) (NYSE: ACB), FSD Pharma (CSE: HUGE), Khiron (TSXV: KHRN), Green Growth (CSE: GGB) and Nextleaf (CSE: OILS)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: DIXI.U) (OTC: DXBRF), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) and Agrios Global Holdings (CSE: AGRO), (OTCQB: AGGHF)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: DIXI.U) (OTC: DXBRF), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) and Agrios Global Holdings (CSE: AGRO), (OTCQB: AGGHF)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: DIXI.U) (OTC: DXBRF), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) and Agrios Global Holdings (CSE: AGRO), (OTCQB: AGGHF)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aurora Cannabis (TSX: ACB) (NYSE: ACB), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Cannabis One Holdings (CSE:CBIS), Liht Cannabis (CSE:LIHT) and FSD Pharma (CSE: HUGE) (OTCQB: FSDDF)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aurora Cannabis (TSX: ACB) (NYSE: ACB), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Cannabis One Holdings (CSE:CBIS), Liht Cannabis (CSE:LIHT) and FSD Pharma (CSE: HUGE) (OTCQB: FSDDF)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aurora Cannabis (TSX: ACB) (NYSE: ACB), Khiron Life Sciences (TSXV: KHRN), (OTCQB: KHRNF), Cannabis One Holdings (CSE:CBIS), Liht Cannabis (CSE:LIHT) and FSD Pharma (CSE: HUGE) (OTCQB: FSDDF)

President Chris Naprawa of Khiron Life Sciences Corp. (OTCQB: AXIM)(TSX.v: KHRN), joins Stock Day to talk about becoming the dominant integrated cannabis company in Latin America: including Mexico and Brazil. # branded products # chronic pain # cultivation # depression # domestic distribution # epilepsy # focused # regional strategy # international export # low cost cultivation # production

Marcela Prieto, directora de Foros Semana, entrevista hoy a Andres Galofre, director comercial y cofundador de Khiron. #PuntoDeEncuentro

Khiron apunta a llegar a más de 65 millones de pacientes en Latinoamérica.See omnystudio.com/listener for privacy information.

Khiron Life Sciences is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe.They currently have distribution throughout various countries in Latin America, along with activity in North America and Europe.The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to the UK, Peru, and Uruguay/Brazil.Alvaro Torres is the founder, CEO, and Director of Khiron. He has almost two decades of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions.